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and pacemaker current inhibition. Am J Physiol Heart Circ Physiol
299: H634 –H642, 2010. First published July 2, 2010;
doi:10.1152/ajpheart.00347.2010.—The mechanisms of sinoatrial
node (SAN) dysfunction in patients with chronically elevated sympa-
thetic tone and reduced pacemaker current (If; such as heart failure)
are poorly understood. We simultaneously mapped membrane poten-
tial and intracellular Ca2 in the Langendorff-perfused canine right
atrium (RA). Blockade of either If (ZD-7288) or sarcoplasmic retic-
ulum Ca2 release (ryanodine) alone decreased heart rate by 8% (n 
3) and 16% (n  3), respectively. Combined treatment of ZD-7288
and ryanodine consistently resulted in prolonged (3 s) sinus pauses
(PSPs) (n  4). However, the middle SAN remained as the leading
pacemaking site after these treatments. Prolonged exposure with
isoproterenol (0.01 mol/l) followed by ZD-7288 completely sup-
pressed SAN but triggered recurrent ectopic atrial tachycardia. Ces-
sation of tachycardia was followed by PSPs in five of eight RAs.
Isoproterenol initially increased heart rate by 75% from baseline with
late diastolic intracellular Ca2 elevation (LDCAE) from the superior
SAN. However, after a prolonged isoproterenol infusion, LDCAE
disappeared in the superior SAN, the leading pacemaker shifted to the
inferior SAN, and the rate reduced to 52% above baseline. Caffeine (2
ml, 20 mmol/l) injection after a prolonged isoproterenol infusion
produced LDCAE in the SAN and accelerated the SAN rate, ruling
out sarcoplasmic reticulum Ca2 depletion as a cause of Ca2 clock
malfunction. We conclude that in an isolated canine RA preparation,
chronically elevated sympathetic tone results in abnormal pacemaking
hierarchy in the RA, including suppression of the superior SAN and
enhanced pacemaking from ectopic sites. Combined malfunction of
both membrane and Ca2 clocks underlies the mechanisms of PSPs.
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SPONTANEOUS DIASTOLIC DEPOLARIZATION of sinoatrial node
(SAN) cells periodically initiates action potentials to set the
rhythm of the heart. The mechanism of spontaneous diastolic
depolarization has been attributed to the rhythmic activation of
the pacemaker current (If) and other membrane ionic currents
(“membrane clock”) and the rhythmic spontaneous sarcoplas-
mic reticulum (SR) Ca2 release and Na/Ca2 exchanger
current (INCX) activation (“Ca2 clock”) (10, 17). It has been
proposed that the membrane clock acts as stabilizer of the
pacemaker rate to prevent bradycardia (18, 20), whereas the
Ca2 clock is primarily responsible for heart rate acceleration
during sympathetic stimulation (16). The SAN is a clinically
important structure, as failure of SAN rhythm generation may
lead to symptomatic bradycardia, known as sick sinus syn-
drome. While bradycardia is the mechanism of symptoms such
as dizziness and presyncope, the onset of bradycardia in sick
sinus syndrome is often immediately preceded by tachycardia.
Therefore, sick sinus syndrome is often referred to as tachy-
bradycardia syndrome (12). Patients with heart failure typically
have abnormal sinus node function. Cessation of rapid pacing
in these patients is followed by a prolonged sinus node recov-
ery time (24). Dogs with pacing-induced heart failure may also
develop typical spontaneous episodes of tachybradycardia
(21). Because heart failure is known to have both chronically
increased circulating catecholamines and downregulated If (6,
29), we hypothesize that If blockade in the presence of pro-
longed sympathetic stimulation could produce tachybradycar-
dia in intact canine right atrial (RA) preparations. The purpose
of the present study was to test this hypothesis.
MATERIALS AND METHODS
Langendorff-perfused canine RA preparation. The study protocol
was approved by the Institutional Animal Care and Use Committee of
Indiana University School of Medicine and the Methodist Research
Institute and conforms with guidelines of the American Heart Asso-
ciation. We studied isolated canine RAs in 21 mongrel dogs (22–28
kg). Hearts were rapidly excised under general anesthesia, and the
right coronary artery was perfused with 37°C Tyrode solution equil-
ibrated with 95% O2-5% CO2 to maintain a pH of 7.4. The compo-
sition of Tyrode solution was (in mmol/l) 125 NaCl, 4.5 KCl, 0.25
MgCl2, 24 NaHCO3, 1.8 NaH2PO4, 1.8 CaCl2, and 5.5 glucose. The
coronary perfusion pressure was regulated between 50 and 60 mmHg.
Both ventricles and the left atrium were removed, and all visible
coronary artery branches were tied off. Contractility was inhibited by
10–17 mol/l blebbistatin, and the motion artifact was negligible
even after the isoproterenol infusion (16). The pseudo-ECG was
recorded with widely spaced bipolar RA electrodes using ISO-
DAM8A (World Precision Instruments). RA preparations were equil-
ibrated for 1 h before baseline measurement (28).
Assessment of SAN function. SAN recovery time (SNRT) was
determined by bipolar pacing with a programmable stimulator (Bloom
Associates, Reading, PA) for 30 s at progressively shorter pacing
cycle lengths (400, 350, and 300 ms) with the two electrodes placed
near the SAN region. The longest time interval from the last paced
atrial depolarization to the first spontaneous sinus beat was recorded
as the SNRT. The corrected SNRT (cSNRT) was determined by
subtracting an average of three sinus cycle lengths before the com-
mencement of atrial pacing from the SNRT.
Dual membrane potential and intracellular Ca2 recordings.
Hearts were stained with rhod-2 AM and RH237 (Molecular Probes,
Eugene, OR) and excited with laser light at 532 nm (16). Fluorescence
was collected using two cameras (MiCAM Ultima, BrainVision,
Tokyo, Japan) at 1 ms/frame and 100  100 pixels with a spatial
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resolution of 0.35  0.35 mm2/pixel for 2 s. The SAN area was
identified by spontaneous diastolic depolarization and confirmed by
histological experiments (trichrome) and by immunostaining of anti-
K/Na hyperpolarization-activated cyclic nucleotide-gated channel
4 (HCN4). After baseline spontaneous beats had been mapped, the
pharmacological interventions were as follows: ZD-7288 (3 mol/l)
infusion (n  3) (8, 16), ryanodine (3 mol/l) infusion (n  3),
ZD-7288 plus ryanodine infusion (n  4), low-dose isoproterenol
(0.01 mol/l) alone infusion for 140 min (n  3), and low-dose
isoproterenol (0.01 mol/l) infusion for 1 h and followed by ZD-7288
(n  8), including four RAs in which caffeine (20 mmol/l, 2 ml) was
given as a bolus injection before and after the prolonged isoproterenol
infusion.
After the combined ZD-7288 and ryanodine infusion, a marked
sinus pause was consistently produced. Therefore, to record the
first and last spontaneous beats between pauses, only membrane
potential (Vm) was recorded at 10 ms/frame for 20 s. The fluores-
cence induced by the laser illumination was obtained through a
common lens, separated with a dichroic mirror (650-nm cutoff
wavelength), and directed to the respective camera with additional
filtering [715-nm long-pass filter for Vm and 580  20 nm for
intracellular Ca2 (Cai2)].
Data analysis. We defined tachybradycardia as the alternation of
paroxysms of rapid (100 beats/min) regular or irregular atrial
tachyarrhythmias followed periods of prolonged sinus pauses (PSPs)
that exceeded 3 s. Cai2 and Vm traces were normalized to their
respective peak-to-peak amplitude for a comparison of timing and
morphology. The onset of late diastolic Cai2 elevation (LDCAE) was
defined by the time of the transition between negative to positive
values in the dCai2/dt curve. The slopes of LDCAE were measured
from the onsets to peak levels of LDCAE. The “90% Cai2 relaxation
time” was measured from the maximum systolic Cai2 to 90%
reduction of Cai2 (16). Data are expressed as means  SE. Student’s
t-tests with Bonferroni’s correction were used to compare the means
of two numeric values. ANOVA with Fisher’s least-significant-dif-
ference post hoc test was used to compare the means among three and
four groups. Pearson’s 2-tests were used to compare two categorical
variables. P values of 0.05 were considered significant.
RESULTS
Effects of membrane clock and Ca2 clock inhibition in the
absence of an isoproterenol infusion. The baseline heart rate of
the 21 RA preparations was 88  10 beats/min (76–110
beats/min). Figure 1A shows that the infusion of ZD-7288 for
30 min deceased heart rate from 89 to 82 beats/min (8%).
The infusion of ZD-7288 (3 mol/l) reduced heart rate by 8%
to 80  4 beats/min (n  3). The infusion of ryanodine for 30
min, which suppresses the Ca2 clock by the inhibition of
cardiac ryanodine receptor 2 (RyR2), decreased heart rate from
89 to 74 beats/min (16%; Fig. 1B). The ryanodine infusion
decreased heart rate by 16% (73.9 8.3 beats/min, n 3; Fig.
1B). The ryanodine infusion in two of three RAs intermittently
Fig. 1. Effects of ZD-7288 (ZD; n  3) or ryanodine alone (n  3) on the sinoatrial node (SAN) in the absence of isoproterenol (Iso). Shown are pseudo-ECGs
of the canine isolated right atrium (RA). A,a: Baseline. Regular atrial activations (p) were found on the pseudo-ECG. b, ZD-7288 (3 mol/l) infusion for 30 min.
B,a: baseline. b, Ryanodine (3 mol/l) infusion for 30 min in the first dog reduced heart rate (HR) by 16%. C: ryanodine (3 mol/l) infusion for 30 min in the
second dog caused an irregular sinus rhythm. a, Intermittent sinus pause induced by ryanodine infusion. b, Extended view of period 1 in C,a. c, Membrane voltage
(Vm) tracings recorded from the inferior (traces a and b), middle (trace c), and superior (trace d) SAN and RA (traces f–h) during period 2 in C,b. Numbers
on Vm tracings show the cycle length (CL; in ms). d, Isochronal map of period 3 in C,c. The isochronal lines are shown in colors. The time of each isochrone
is marked by a number (in ms), with the time of the first activation as time 0. Numbers on Vm isochronal maps are in milliseconds. SVC; superior vena cava,
RAA; right atrial appendage, A, anterior; P, posterior; S, superior; I, inferior; bpm, beats/min.
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impaired the regularity of sinus rhythm, producing short and
recurrent sinus pauses (Fig. 1B). These pauses were preceded
by transient tachycardia caused by the acceleration of pace-
makers in the inferior SAN (Fig. 1C). Neither ZD-7288 nor
ryanodine produced sinus pauses that exceeded 3 s. However,
simultaneous use of these two drugs produced PSPs. Fig. 2
shows the effect of a combined infusion of both ZD-7288 (3
mol/l) and ryanodine (3 mol/l) without isoproterenol infu-
sion. Figure 2A shows sinus pauses of 6.9 and 6.3 s. In all 4
dogs treated with both ZD-7288 and ryanodine, 59 episodes of
PSPs with a mean duration of 6.4  1.9 s (range: 3–18 s) were
produced. Figure 2B shows isochronal maps of the first (a) and
last (b) spontaneous beats between the pauses. Both beats
originated from the middle SAN. All 171 beats recorded
between pauses in this RA originated from the middle SAN.
Similarly, in all RAs mapped, the leading pacemakers during
combined ZD-7288 and ryanodine treatment were located in
the middle SAN and not from the inferior SAN or ectopic sites.
The mean of the first cycle length after the pause was signif-
icantly shorter than that of the last cycle length (857.8  71.7
vs. 1160.5  212.4 ms, P  0.001; Fig. 2C). Although a pause
(3 s) was successfully generated by blockade of both If and
SR Ca2 release, typical episodes of tachycardia (100 beats/
min) in the tachybradycardia syndrome were not observed. The
mean cycle length between the pause was 804  135 ms
(range: 710–1,171 ms).
Effect of a prolonged low-dose isoproterenol infusion on
pacemaker hierarchy. Figure 3A shows a typical episode of
heart rate change by a prolonged low-dose isoproterenol infu-
sion of 0.01 mol/l followed by a ZD-7288 infusion of 3
mol/l. Figure 3B shows the baseline rhythm generation. The
heart rhythm was generated from the middle SAN (sites c and
d in Fig. 3B), and diastolic depolarization was observed from
SAN regions (asterisks in Fig. 3B). Figure 3C shows the
response to the isoproterenol infusion during maximum heart
rate. The leading pacemaker site was shifted to the superior
SAN with LDCAE (asterisks in Fig. 3C, bottom). In a total of
11 intact canine RAs, low-dose (0.01 mol/l) isoproterenol
increased the mean maximum heart rate to 145 21 beats/min
(71%) from a baseline of 85  12 beats/min (P  0.004).
However, during the prolonged isoproterenol infusion (1 h),
heart rate was reduced to 129  19 beats/min (52% from
baseline) with disappearance of LDCAE (site d in Fig. 3D).
The reduced heart rate was maintained for 140 min (n  3,
52% from baseline). The earliest activation site also changed to
the inferior SAN (site e in Fig. 3D). The downward shift of the
leading pacemaking site in the SAN was a consistent finding of
all RAs studied. These findings indicate that a prolonged
low-dose isoproterenol infusion selectively inhibits the supe-
rior SAN and changes the hierarchy of pacemaking sites in the
SAN. The ZD-7288 (3 mol/l) infusion at this time further
decreased heart rate to 92  13 beats/min (8% from baseline;
site e in Fig. 3D) with more inferior shift of the leading
pacemaker site (site f in Fig. 3E). The difference of heart rate
between site d (129  19 beats/min) and site e (92  13
beats/min) in Fig. 3A was statistically significant (P  0.003).
Prolonged isoproterenol and ZD-7288 infusion produced
tachybradycardia. We were able to produce an in vitro model
of tachybradycardia after prolonged (1 h) exposure to low-
dose (0.01 mol/L) isoproterenol and subsequent blockade of
If by ZD-7288 in five (63%) of eight RA preparations. Figure 4
shows examples of tachybradycardia recorded from two
different canine RAs. Figure 4A shows eight episodes of
tachybradycardia. The RA shown in Fig. 4B demonstrated
three episodes of tachybradycardia. During 29 episodes of
tachybradycardia, the mean of the first cycle length after the
pause was significantly longer than that of the last cycle
length (1,917.8  457.5 vs. 505.4  148.9 ms, P  0.001;
Fig. 4C). Acceleration of the heart rate leading to eventual
tachycardia can be observed after the PSP in these episodes.
Fig. 2. Effects of a simultaneous infusion of ZD and ryanodine in the absence of Iso (n  4). A: pseudo-ECG during simultaneous ZD and ryanodine infusion
for 30 min showing 2 episodes of sinus pauses. B: isochronal maps of the first (a) and last (b) spontaneous beats originated from the middle SAN. The SAN
is outlined with a dashed line. C: comparison of the first and last CLs between pauses. The mean CL of the first beat after the pause was significantly shorter
than that of the last beat (P  0.001).
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Importantly, prolonged isoproterenol infusion was essential
in all episodes to produce tachybradycardia. Tachybrady-
cardia was not produced by ZD-7288 alone, without a
previous prolonged isoproterenol infusion (n  5). Note that
tachycardia (100 beats/min) appeared in the results shown
in Fig. 4 but not in Fig. 2.
The origin of heart beat during tachybradycardia. Figure 5,
A and B, shows optical recordings of the tachybradycardia
episode shown in Fig. 4A. During the beginning of tachycardia,
the activation originated from the ectopic site of the anterosu-
perior RA (Fig. 5B). Before the termination of tachycardia,
alternation of heart rhythm was caused by the activation from
the lower SAN (beat 2 in Fig. 5B) and ectopic sites from the
inferior RA (beat 3 in Fig. 5B). After the sinus pause, a
spontaneous beat was generated from the inferior SAN without
LDCAE (beat 4 in Fig. 5B). Optical recordings of the RA
preparation shown in Fig. 4B are shown in Fig. 5, C and D.
Tachycardia originated from the ectopic site from the infero-
posterior RA (beat 1 in Fig. 5D). The ectopic site from the
inferoposterior RA served as the leading pacemaker site until
the termination of tachycardia (beat 2 in Fig. 5D). After a
pause of the ectopic beat, the spontaneous beat was produced
from the inferior SAN without LDCAE (beat 3 in Fig. 5D).
Contrary to that found at baseline (before isoproterenol), the
leading pacemaking sites after the prolonged isoproterenol
infusion were mostly located either at an ectopic site or in the
inferior edge of the SAN. Cai2 and Vm were simultaneously
recorded in total 90 beats, including 72 fast beats and 18 slow
beats during tachybradycardia. All 18 slow beats originated
from the inferior SAN. Among the 72 fast beats, 68 beats
(94%) originated from ectopic foci. The remaining four beats
were initiated from either the inferior SAN (3 beats) or the
superior SAN (1 beat).
Preserved SR Ca2 content after a prolonged low-dose
isoproterenol infusion. To evaluate the cause of impaired
superior SAN function after a prolonged low-dose isoprotere-
nol infusion, we injected 2 ml caffeine (20 mmol/l) for 1 s in
four RAs. Caffeine produced LDCAE in the SAN without
(asterisks in Fig. 6A) and with a prolonged low-dose isopro-
terenol infusion (asterisks in Fig. 6B). Before the prolonged
isoproterenol infusion, the leading pacemaker site during caf-
feine infusion was at the superior SAN in all four RAs.
However, after the prolonged isoproterenol infusion, it
changed to ectopic foci in all four RAs (P  0.03). The
LDCAE slopes after the prolonged isoproterenol infusion
(3.88  0.88 arbitrary units/s) showed no significant differ-
Fig. 3. Effect of a prolonged low-dose Iso infusion (n  8). A: HR trends after a prolonged (1 h) isoproterenol infusion of 0.01 mol/l. HR was increased to
a maximum at 5 min, decreased after 10 min, and maintained for 140 min (black line, n  3). ZD infusion (3 mol/l) decrease HR close to the baseline level
(red line, n  8). B–E: Vm isochronal maps of the SAN and surrounding RA (top) and intracellular Ca2 (Cai2; red) and Vm (blue) tracings from the superior
(sites a and b), middle (sites c and d), and lower (sites e and f) SAN. B: baseline. Note the diastolic depolarization (*) in the SAN. C: Iso infusion for 5 min.
Note the late diastolic Cai2 elevation (LDCAE; *) from the superior SAN. D: Iso infusion for 1 h. Note the disappearance of LDCAE with shifting of the leading
pacemaker site to the inferior SAN (site e). E: ZD infusion for 30 min. The pacemaker site shifted to the more inferior SAN (site f). Numbers on the Vm isochronal
maps are in milliseconds. AU, arbitrary units.
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ences compared with those before the isoproterenol infusion
(3.60  0.74 arbitrary units/s, P  0.64; Fig. 6C). Heart
rates after the prolonged isoproterenol infusion (172  7
beats/min) showed no significant differences compared with
those before the isoproterenol infusion (174  8 beats/min,
P  0.84; Fig. 6D). This finding suggests that the SR Ca2
content is preserved after a prolonged low-dose isoprotere-
nol infusion.
Comparison of SNRT, LDCAE slope, and Cai2 relaxation
time. SNRT was 912  212, 684  45, and 1,144  295 ms
and cSNRT was 208  110, 152  38, and 502  203 ms
at baseline, after the 5-min isoproterenol infusion, and after
the combined ZD-7288 and prolonged isoproterenol infu-
sion, respectively (Fig. 7, A and B, respectively). Compared
with baseline, isoproterenol initially reduced SNRT, but the
combined use of prolonged isoproterenol infusion and ZD-
7288 significantly increased both SNRT (Fig. 7A) and
cSNRT (Fig. 7B) compared with baseline. Figure 7C shows
that the LDCAE slope increased significantly after 5 min of the
low-dose isoproterenol infusion, when the isoproterenol effects
on heart rate reached their peak. The LDCAE slope then
decreased toward baseline after the prolonged isoproterenol
infusion and after the addition of ZD-7288 (Fig. 7C). Figure
7D shows the changes of 90% Cai2 relaxation time. Initially,
isoproterenol reduced the relaxation time. However, after the
prolonged isoproterenol infusion and after the addition of
ZD-7288, the relaxation time returned to the baseline level.
DISCUSSION
The primary finding of this study is that ZD-7288 infusion in
the presence of a prolonged (1 h) isoproterenol infusion
results in combined malfunction of the Ca2 clock and mem-
brane voltage clock in the SAN but, in the meantime, facilitates
the development of paroxysmal ectopic atrial tachycardia. Due
to combined deficiency of the Ca2 clock and membrane
voltage clock of both the SAN and backup pacemakers, abrupt
termination of the tachycardia results in PSP. Because the SAN
continued to respond to caffeine at the end of the isoproterenol
infusion, the Ca2 clock malfunction was not due to SR Ca2
depletion.
Mechanisms of tachybradycardia. A prolonged (	1 h) iso-
proterenol infusion simulates persistently elevated sympathetic
tone, which is typical in patients with heart failure but can also
occur in normal individuals. The persistently elevated sympa-
thetic tone by itself does not induce tachybradycardia. How-
ever, If blockade in the presence of prolonged sympathetic
stimulation could produce tachybradycardia. This finding high-
lights the importance of If in maintaining normal SAN function
under conditions with persistently increased sympathetic tone,
such as heart failure. Similar to the experimental condition,
heart failure is associated with both chronically elevated sym-
pathetic tone (2) (21) and a concomitant reduction of If (29).
The chronically increased sympathetic tone is known to have
profound effects on cardiac contractile function and arrhyth-
Fig. 4. Tachybradycardia produced by prolonged isoproterenol and ZD infusion. Shown are pseudo-ECGs from the canine isolated RA. A: tachybradycardia from
the first dog. Top, eight episodes of tachybradycardia; bottom, expanded view of the indicated section (*) showing 4.0- and 3.5-s pauses. B: tachybradycardia
from a second RA. Top, three episodes of tachybradycardia; bottom, expanded view of the indicated section (*) showing a 4.2-s pause. C: comparison of the
first and last CLs between pauses.
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mogenesis (7, 22). However, the effects of chronic catechol-
amine stimulation on the SAN remains poorly understood. Our
study is the first to map Ca2 clock function in the SAN during
a prolonged isoproterenol infusion. The LDCAE slope and
90% Cai2 relaxation time reached peak at 5  2 min after the
isoproterenol infusion and decreased after the prolonged infu-
sion. A possible explanation of our finding is isoproterenol
induced desensitization of the 
-adrenergic receptor (6, 14).
However, for this explanation to work, it will require a selec-
tive desensitization of the 
-adrenergic receptor in the SAN but
not the ectopic sites that generate recurrent ectopic atrial
tachyarrhythmias during a prolonged isoproterenol infusion.
Isoproterenol induced phosphorylation of RyR2. An alterna-
tive explanation is the accelerated opening and closing of the
RyR2 after a prolonged isoproterenol infusion in the superior
SAN, which has more robust Cai2 cycling than the inferior
SAN and nonpacemaking cells in the RA and ventricles (16,
27). Sympathetic stimulation can result in the phosphorylation
of ICaL and phospholamban, leading to increased SR Ca2
content (26). It can also phosphorylate RyR2, leading to
increased opening probability. A combined increase of SR
Ca2 content and the opening probability of RyR2 is essential
in producing arrhythmogenic Ca2 waves (26). A recent study
by Blayney et al. (4) investigated PKA phosphorylation with
binding of FK506-binding proteins to RyRs, including both
RyR1 and RyR2. The authors phosphorylated RyR1 and RyR2
using the active subunit of PKA over 1 h. The results showed
that the percentage of phosphorylation reached its maximum in
1 h. When phosphorylated, RyR2 opens and closes more
quickly. We also found that at least 1 h of isoproterenol
infusion is needed to produce tachybradycardia in our prepa-
ration. This time course is consistent with the time needed for
isoproterenol to activate PKA and maximally phosphorylate
RyR2. The balance between the opening and closing of RyR2
determines how much Ca2 is released from the SR to the
cytosol. Consistent with the results of a previous study (15), we
found no evidence of SR Ca2 depletion in the SAN at the end
of the experiment. This finding suggests that reduced SR Ca2
reuptake is not primarily responsible for SAN dysfunction after
a prolonged isoproterenol infusion. Therefore, it is likely that
excessively rapid RyR2 closing in the superior SAN may have
prevented sufficient spontaneous SR Ca2 release after a pro-
longed isoproterenol infusion, leading to PSPs. Finally, at a
given Em, the elevated concentration of Cai2 slows the recov-
ery of L-type Ca2 current from inactivation (1). This latter
factor may also have contributed to the development of SAN
dysfunction.
Ectopic pacemakers. The pacemaker hierarchy in the RA
operates with different mechanisms. The Ca2 clock in the
superior SAN responds robustly to isoproterenol infusion (16).
However, if RyR2 is inhibited by ryanodine, the superior SAN
became quiescent during isoproterenol infusion, whereas the
Fig. 5. Comparison of activation sites during tachybradycardia. A: pseudo-ECG of one episode of tachybradycardia from Fig. 4A. B: isochronal maps of the beats
marked in A. Regular tachycardia with a CL of 480 ms originated from the anterosuperior RA (beat 1). Irregular tachycardia with alternans was observed before
the prolonged pause (beats 2 and 3). Beats 2 and 3 were generated from the inferior SAN and inferior RA, respectively. The slow rhythm after a sinus pause
originated from the inferior SAN (beat 4). C: pseudo-ECG of one episode of tachybradycardia from Fig. 4B. D: isochronal maps of the beats marked in C. Regular
tachycardia with a CL of 475 ms originated from the inferoposterior RA (beats 1 and 2). The slow rhythm after a sinus pause originated from the inferior SAN
(beat 3). Numbers on the Vm isochronal maps are in milliseconds.
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ectopic pacemaker sites in the crista terminalis continue to
actively respond to isoproterenol and accelerate heart rate (25).
We found that the ectopic pacemakers are highly active after a
prolonged isoproterenol infusion, resulting in intermittent ec-
topic tachycardia while the superior SAN remains dormant.
Therefore, heterogeneous and dynamic responses of the pace-
maker hierarchy to chronically elevated sympathetic tone play
important roles in the generation of tachybradycardia syn-
drome. We also found that even without isoproterenol infusion,
the combined use of ryanodine and ZD-7288 also produced
irregular heart rhythms. However, contrary to that found in
tachybradycardia, the latter irregular rhythm originated from
D
Fig. 6. Response to a bolus caffeine injection
after a prolonged low-dose Iso infusion (n 
4). A: effect of a bolus caffeine (20 mmol/l)
injection in the normal RA. Note the superior
shift of the leading pacemaker site with ro-
bust LDCAE (*) with a HR of 127 beats/
min. B: effect of a bolus caffeine injection
after a prolonged low-dose Iso infusion.
Note the robust LDCAE (*) from the supe-
rior SAN. The leading pacemaker site was
the inferior RA with a HR of 150 beats/min.
C: comparison of LDCAE slopes during caf-
feine alone and Iso plus caffeine infusion.
D: comparison of HRs during caffeine alone
and Iso plus caffeine infusion.
Fig. 7. A and B: change of SAN recovery time
(SNRT; A) and corrected SNRT (cSNRT;
B) after a prolonged Iso infusion and ZD infu-
sion. C and D: change of LDCAE slope (C) and
90% Cai2 relaxation time (D) at the peak and 1
h after Iso and combined Iso and ZD infusion.
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the middle of the SAN. The mechanism of these irregular
rhythms is mostly likely due to If inhibition, which creates long
pauses, allowing the SR to be overfilled with Ca2. Although
RyR2 is partially inhibited by ryanodine, the luminal Ca2 of
the superior SAN eventually exceeded the RyR2 releasing
threshold, leading to sinus tachycardia. The gradual decline of
intraluminal Ca2 then causes a lengthening of sinus cycle
length and transient termination of sinus rhythm. The cycle of
long pauses and accelerated SAN rate repeats itself, causing
irregular SAN rhythm.
Tachycardia-induced intracellular Na accumulation. An
additional possible contributing factor to the occurrence of
tachybradycardia is the increased intracellular Na load (9,
13). The increased intracellular Na may increase the extru-
sion of Na from the cell by Na-K-ATPase to produce an
increased background repolarizing current, which slows phase
4 diastolic depolarization (5), causing the tachycardia to tran-
siently terminate. Increased intracellular Na may also sup-
press the forward mode of INCX, which prevents Cai2 from
depolarizing the cell membrane, leading to the termination of
the tachycardia. The PSP then allowed sufficient Na to be
extruded through Na-K-ATPase and allowed the develop-
ment of another episode of tachycardia. This additional mech-
anism is not mutually exclusive with the RyR phosphorylation
discussed above. However, tachycardia-induced excessive in-
tracellular Na accumulation cannot explain the findings of
irregular rhythm during combined treatment of ryanodine and
ZD-7288.
PSPs occur only if both membrane and Ca2 clocks are
impaired. PSPs were produced only after block of both SR
Ca2 release and If. Although Ca2 clock block alone de-
stroyed the regularity of heart rhythm, PSPs did not develop
afterward. Clinically, pharmacological agents that suppress If
reduce the heart rate but do not lead to PSPs (11). Similarly,
patients with HCN4 mutation that reduces If develop benign
familial bradycardia but not PSPs or syncope (19). Patients
with RyR2 mutation typically develop bradycardia but not
PSPs (3). These findings are consistent with studies (16–18)
that have demonstrated interdependence and synergy between
the Ca2 clock and membrane clock in generating heart betas.
A mapping study (25) has also shown that the inferior SAN
works as the dominant pacemaker even after blockade of both
clock mechanisms, suggesting that the different locations of
the SAN may have different dependence of these clocks in
generating automaticity.
Study limitations. Because the ectopic foci were not included
in the optical mapping field, the exact relationship between
Cai2 and Vm in the generation of ectopic beat cannot be
evaluated, but If is likely to be responsible for the initiation of
these ectopic beats. Because vagal innervation is absent in the
isolated canine RA preparation, the effects of vagal activation
on SAN rate control cannot be determined in the present study.
The absence of vagal influence may have contributed to some
of the findings of the present study.
Conclusions. Our results from the isolated canine RA show
that tachybradycardia occurs by prolonged (1 h) exposure to

-adrenergic stimulation and a concomitant suppression of If.
Maximal RyR2 phosphorylation and intracellular Na accu-
mulation in the SAN are possible mechanisms that contribute
to the development of tachybradycardia in patients with chron-
ically elevated sympathetic tones.
ACKNOWLEDGMENTS
The authors thank Lei Lin and Erica Foster for assistance.
GRANTS
This work was supported in part by National Heart, Lung, and Blood
Institute Grants P01-HL-78931, R01-HL-78932, and HL-71140, Faculty Re-
search Grant 6-2009-0176, and Yonsei University College of Medicine CMB-
YUHAN Research Grant 7-2009-0583 (to B. Joung), Chinese National Natural
Science Foundation Grant 30870659 (to H. Zhang), Medtronic-Zipes Endow-
ments (to P.-S. Chen), and by an American Heart Association Established
Investigator Award (to S.-F. Lin).
DISCLOSURES
No conflicts of interest, financial or otherwise, are declared by the author(s).
REFERENCES
1. Altamirano J, Bers DM. Effect of intracellular Ca2 and action potential
duration on L-type Ca2 channel inactivation and recovery from inacti-
vation in rabbit cardiac myocytes. Am J Physiol Heart Circ Physiol 293:
H563–H573, 2007.
2. Anand IS, Fisher LD, Chiang YT, Latini R, Masson S, Maggioni AP,
Glazer RD, Tognoni G, Cohn JN. Changes in brain natriuretic peptide
and norepinephrine over time and mortality and morbidity in the Valsartan
Heart Failure Trial (Val-HeFT). Circulation 107: 1278–1283, 2003.
3. Bhuiyan ZA, Van Den Berg MP, van Tintelen JP, Bink-Boelkens MT,
Wiesfeld AC, Alders M, Postma AV, van LI, Mannens MM, Wilde
AA. Expanding spectrum of human RYR2-related disease: new electro-
cardiographic, structural, and genetic features. Circulation 116: 1569–
1576, 2007.
4. Blayney LM, Jones JL, Griffiths J, Lai FA. A mechanism of ryanodine
receptor modulation by FKBP12/12.6, protein kinase A, and K201. Car-
diovasc Res 85: 68–78, 2010.
5. Boyett MR, Fedida D. Changes in the electrical activity of dog cardiac
Purkinje fibres at high heart rates. J Physiol 350: 361–391, 1984.
6. Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman WS,
Lurie K, Billingham ME, Harrison DC, Stinson EB. Decreased cate-
cholamine sensitivity and 
-adrenergic-receptor density in failing human
hearts. N Engl J Med 307: 205–211, 1982.
7. Bristow MR, Krause-Steinrauf H, Nuzzo R, Liang CS, Lindenfeld J,
Lowes BD, Hattler B, Abraham WT, Olson L, Krueger S, Thaneemit-
Chen S, Hare JM, Loeb HS, Domanski MJ, Eichhorn EJ, Zelis R,
Lavori P. Effect of baseline or changes in adrenergic activity on clinical
outcomes in the 
-blocker evaluation of survival trial. Circulation 110:
1437–1442, 2004.
8. Bucchi A, Barbuti A, Baruscotti M, DiFrancesco D. Heart rate reduc-
tion via selective “funny” channel blockers. Curr Opin Pharmacol 7:
208–213, 2007.
9. Cohen CJ, Fozzard HA, Sheu SS. Increase in intracellular sodium ion
activity during stimulation in mammalian cardiac muscle. Circ Res 50:
651–662, 1982.
10. Difrancesco D. The role of the funny current in pacemaker activity. Circ
Res 106: 434–446, 2010.
11. Fox K, Ford I, Steg PG, Tendera M, Robertson M, Ferrari R. Heart
rate as a prognostic risk factor in patients with coronary artery disease and
left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis
of a randomised controlled trial. Lancet 372: 817–821, 2008.
12. Gomes JA, Kang PS, Matheson M, Gough WB Jr, El Sherif N.
Coexistence of sick sinus rhythm and atrial flutter-fibrillation. Circulation
63: 80–86, 1981.
13. Graziani AT, Vassalle M. Mechanisms underlying overdrive suppression
and overdrive excitation in guinea pig sino-atrial node. J Biomed Sci 13:
703–720, 2006.
14. Hart E, Dawson E, Rasmussen P, George K, Secher NH, Whyte G,
Shave R. 
-Adrenergic receptor desensitization in man: insight into
post-exercise attenuation of cardiac function. J Physiol 577: 717–725,
2006.
15. Hussain M, Orchard CH. Sarcoplasmic reticulum Ca2 content, L-type
Ca2 current and the Ca2 transient in rat myocytes during 
-adrenergic
stimulation. J Physiol 505: 385–402, 1997.
16. Joung B, Tang L, Maruyama M, Han S, Chen Z, Stucky M, Jones LR,
Fishbein MC, Weiss JN, Chen PS, Lin SF. Intracellular calcium dynam-
H641MECHANISM OF TACHYBRADYCARDIA
AJP-Heart Circ Physiol • VOL 299 • SEPTEMBER 2010 • www.ajpheart.org
ics and acceleration of sinus rhythm by 
-adrenergic stimulation. Circu-
lation 119: 788–796, 2009.
17. Lakatta EG, Maltsev VA, Vinogradova TM. A coupled SYSTEM of
intracellular Ca2 clocks and surface membrane voltage clocks controls
the timekeeping mechanism of the heart’s pacemaker. Circ Res 106:
659–673, 2010.
18. Maltsev VA, Lakatta EG. A novel quantitative explanation for auto-
nomic modulation of cardiac pacemaker cell automaticity via a dynamic
system of sarcolemmal and intracellular proteins. Am J Physiol Heart Circ
Physiol 298: H2010–H2023, 2010.
19. Milanesi R, Baruscotti M, Gnecchi-Ruscone T, DiFrancesco D. Famil-
ial sinus bradycardia associated with a mutation in the cardiac pacemaker
channel. N Engl J Med 354: 151–157, 2006.
20. Noble D, Denyer JC, Brown HF, DiFrancesco D. Reciprocal role of the
inward currents ib, Na and if in controlling and stabilizing pacemaker
frequency of rabbit sino-atrial node cells. Proc Biol Sci 250: 199–207,
1992.
21. Ogawa M, Zhou S, Tan AY, Song J, Gholmieh G, Fishbein MCLH,
Siegel RJ, Karagueuzian HS, Chen LS, in SF, Chen PS. Left stellate
ganglion and vagal nerve activity and cardiac arrhythmias in ambulatory
dogs with pacing-induced congestive heart failure. J Am Coll Cardiol 50:
335–343, 2007.
22. Rubart M, Zipes DP. Mechanisms of sudden cardiac death. J Clin Invest
115: 2305–2315, 2005.
23. Sanders P, Berenfeld O, Hocini M, Jais P, Vaidyanathan R, Hsu LF,
Garrigue S, Takahashi Y, Rotter M, Sacher F, Scavee C, Ploutz-
Snyder R, Jalife J, Haissaguerre M. Spectral analysis identifies sites of
high-frequency activity maintaining atrial fibrillation in humans. Circula-
tion 112: 789–797, 2005.
24. Sanders P, Kistler PM, Morton JB, Spence SJ, Kalman JM. Remod-
eling of sinus node function in patients with congestive heart failure:
reduction in sinus node reserve. Circulation 110: 897–903, 2004.
25. Shinohara T, Joung B, Kim D, Maruyama M, Luk HN, Chen PS, Lin
SF. Induction of atrial ectopic beats with calcium release inhibition: local
hierarchy of automaticity in the right atrium. Heart Rhythm 7: 110–116,
2010.
26. Venetucci LA, Trafford AW, Eisner DA. Increasing ryanodine receptor
open probability alone does not produce arrhythmogenic calcium waves:
threshold sarcoplasmic reticulum calcium content is required. Circ Res
100: 105–111, 2007.
27. Vinogradova TM, Lyashkov AE, Zhu W, Ruknudin AM, Sirenko S,
Yang D, Deo S, Barlow M, Johnson S, Caffrey JL, Zhou YY, Xiao RP,
Cheng H, Stern MD, Maltsev VA, Lakatta EG. High basal protein
kinase A-dependent phosphorylation drives rhythmic internal Ca2 store
oscillations and spontaneous beating of cardiac pacemaker cells. Circ Res
98: 505–514, 2006.
28. Woods WT, Urthaler F, James TN. Spontaneous action potentials of
cells in the canine sinus node. Circ Res 39: 76–82, 1976.
29. Zicha S, Fernandez-Velasco M, Lonardo G, L’Heureux N, Nattel S.
Sinus node dysfunction and hyperpolarization-activated (HCN) channel
subunit remodeling in a canine heart failure model. Cardiovasc Res 66:
472–481, 2005.
H642 MECHANISM OF TACHYBRADYCARDIA
AJP-Heart Circ Physiol • VOL 299 • SEPTEMBER 2010 • www.ajpheart.org
